Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20000082HPVENSG00000068078.20protein_codingFGFR3YesNo2261P22607
Q0IJ44
TVIS20007360HPVENSG00000068078.20protein_codingFGFR3YesNo2261P22607
Q0IJ44
TVIS20027601HPVENSG00000068078.20protein_codingFGFR3YesNo2261P22607
Q0IJ44
TVIS20027588HPVENSG00000068078.20protein_codingFGFR3YesNo2261P22607
Q0IJ44
TVIS20015105HPVENSG00000068078.20protein_codingFGFR3YesNo2261P22607
Q0IJ44
TVIS20019576HPVENSG00000068078.20protein_codingFGFR3YesNo2261P22607
Q0IJ44
TVIS20019577HPVENSG00000068078.20protein_codingFGFR3YesNo2261P22607
Q0IJ44
TVIS20030913HPVENSG00000068078.20protein_codingFGFR3YesNo2261P22607
Q0IJ44
TVIS44013030HTLV-1ENSG00000068078.20protein_codingFGFR3YesNo2261P22607
Q0IJ44
TCGA Plot Options
Drug Information
GeneFGFR3
DrugBank IDDB12147
Drug NameErdafitinib
Target IDBE0002133
UniProt IDP22607
Regulation Typeinhibitor
PubMed IDs28965185; 26324363
CitationsNishina T, Takahashi S, Iwasawa R, Noguchi H, Aoki M, Doi T: Safety, pharmacokinetic, and pharmacodynamics of erdafitinib, a pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor, in patients with advanced or refractory solid tumors. Invest New Drugs. 2018 Jun;36(3):424-434. doi: 10.1007/s10637-017-0514-4. Epub 2017 Sep 30.@@Tabernero J, Bahleda R, Dienstmann R, Infante JR, Mita A, Italiano A, Calvo E, Moreno V, Adamo B, Gazzah A, Zhong B, Platero SJ, Smit JW, Stuyckens K, Chatterjee-Kishore M, Rodon J, Peddareddigari V, Luo FR, Soria JC: Phase I Dose-Escalation Study of JNJ-42756493, an Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients With Advanced Solid Tumors. J Clin Oncol. 2015 Oct 20;33(30):3401-8. doi: 10.1200/JCO.2014.60.7341. Epub 2015 Aug 31.
GroupsApproved; Investigational
Direct ClassificationAlkyldiarylamines
SMILESCOC1=CC(=CC(OC)=C1)N(CCNC(C)C)C1=CC=C2N=CC(=NC2=C1)C1=CN(C)N=C1
Pathways
PharmGKB
ChEMBLCHEMBL3545376